Who
Flavia Borellini
Director
Company insider
Files Form 4 as: Director, Pliant Therapeutics; Director, Revolution Medicines; Director, Viracta Therapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 22 Jun 2021
- Last trade
- 9 Jul 2026
- Last filed
- 13 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 13 Jul 2026 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —1,191 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,127 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,127 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —1,191 at $0.00 | filing |
| 26 Jun 2025filed 30 Jun 2025 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,574 at $0.00 | filing |
| 26 Jun 2025filed 30 Jun 2025 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —3,142 at $0.00 | filing |
| 20 Jun 2024filed 28 Jun 2024 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,955 at $0.00 | filing |
| 20 Jun 2024filed 28 Jun 2024 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —4,248 at $0.00 | filing |
| 20 Jun 2024filed 24 Jun 2024 | Viracta Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 20 Jun 2024filed 24 Jun 2024 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 20 Jun 2024filed 24 Jun 2024 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —4,800 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,400 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —5,200 at $0.00 | filing |
| 8 Jun 2023filed 9 Jun 2023 | Viracta Therapeuticsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,400 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code A | —5,200 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | Viracta Therapeuticsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 16 Aug 2021filed 17 Aug 2021 | Viracta Therapeuticsoption or derivative | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.